SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022036
Filing Date
2022-11-04
Accepted
2022-11-04 06:05:23
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcab-20220930.htm   iXBRL 10-Q 2588599
2 EX-10.2 bcab-ex10_2.htm EX-10.2 565680
3 EX-31.1 bcab-ex31_1.htm EX-31.1 21223
4 EX-31.2 bcab-ex31_2.htm EX-31.2 21315
5 EX-32.1 bcab-ex32_1.htm EX-32.1 20492
  Complete submission text file 0000950170-22-022036.txt   8140603

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bcab-20220930_def.xml EX-101.DEF 161854
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bcab-20220930.xsd EX-101.SCH 44157
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bcab-20220930_pre.xml EX-101.PRE 271216
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bcab-20220930_lab.xml EX-101.LAB 369699
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bcab-20220930_cal.xml EX-101.CAL 39775
53 EXTRACTED XBRL INSTANCE DOCUMENT bcab-20220930_htm.xml XML 1186504
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39787 | Film No.: 221360048
SIC: 2836 Biological Products, (No Diagnostic Substances)